See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.88▲ 1.98%
← 0K34 page
XStocksXray
Market X-Ray report · 27 October 2026

Monster Beverage Corp (0K34)

London Stock Exchange · UK · prices in USD · close of 27 Oct 2026

Key indicators

Last closeUSD 45.36
52-week range31.97 – 52.50
Return, 1 month / 3 months+5.3% / −4.8%
Return, 1 year / 3 years+29.7% / +82.2%
TrendUptrend
RSI (14)52
Volatility (1 year)26.3%
Worst drawdown (1 year)-17.2%
Average daily value traded0.67M USD
Dividend yield–

Market X-Ray price-based

65/ 100 · High confidence · ahead of 77% of stocks on this exchange
Trend67
Momentum63
Stability (higher is calmer)76
Liquidity49
Income–

Five-year price chart navy: price · brown: 200-day average

16.5625.3134.0642.8151.572021-102023-012024-042025-072026-10

About the company

Monster Beverage Corp makes and markets energy drinks and other beverages. Its main brand, Monster Energy, is sold in cans through distributors, retailers and convenience stores, and the company also offers coffee-style energy drinks, sports drinks and similar products. The company is based in Corona, California, and its drinks reach customers in many countries through bottlers and wholesale partners.

On this site Monster Beverage Corp appears as a stock on the London Stock Exchange (UK), code 0K34, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Monster Beverage Corp (0K34) trades on the London Stock Exchange in UK. It last closed at USD 45.36 on 27 October 2026.

Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 888 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 29.7% and over the last three months it fell 4.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Monster Beverage Corp (0K34)

The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange

Lens and metricValueScoreReading
Trend67 · FairMixed trend against its averages.
Above 200-day average5.5%
From 52-week high-8.7%
Momentum63 · FairTypical recent returns for this exchange.
3-month return-4.8%
6-month return17.5%
12-month return, skipping the last month23.2%
Stability (higher is calmer)76 · StrongCalmer than most: low volatility and shallow drawdowns.
Volatility, 1 year (lower is calmer)26.3%
Worst drawdown, 1 year (smaller is calmer)-17.2%
Liquidity49 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.67M USD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−3.4%
1 month+5.3%
3 months−4.8%
6 months+17.5%
1 year+29.7%
3 years+82.2%
5 years+112.7%

Signals

50-day / 200-day average44.86 / 43.00
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.61

Technical summary

DailyBullish9 bullish · 4 neutral · 3 bearish
WeeklyStrongly bullish10 bullish · 1 neutral · 1 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026